# Pulsed ElectRic FiEld Versus Cryoballoon for PAF

Study · id `cardio:ct-nct07100834` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07100834](<https://clinicaltrials.gov/study/NCT07100834>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07100834

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 269 participants.

## Technical summary

Registry record NCT07100834. Randomized; single masking; primary purpose treatment. Start 2023-09-27 (actual); primary completion 2024-05-30 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 269 participants (enrolled count; ClinicalTrials.gov record NCT07100834, source copy `cardio:ctgov-nct07100834-2025-08-03`, retrieved 2026-10-26)
- Started: 2023-09-27 (actual) (ClinicalTrials.gov record NCT07100834, source copy `cardio:ctgov-nct07100834-2025-08-03`, retrieved 2026-10-26)
- Primary completion: 2024-05-30 (actual) (ClinicalTrials.gov record NCT07100834, source copy `cardio:ctgov-nct07100834-2025-08-03`, retrieved 2026-10-26)
- Completion: 2025-06-30 (actual) (ClinicalTrials.gov record NCT07100834, source copy `cardio:ctgov-nct07100834-2025-08-03`, retrieved 2026-10-26)
- Countries: Belgium; Croatia; Greece; Italy; Poland (ClinicalTrials.gov record NCT07100834, source copy `cardio:ctgov-nct07100834-2025-08-03`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07100834-2025-08-03`, retrieved 2026-10-26)

## The registry's words

- Brief title: Pulsed ElectRic FiEld Versus Cryoballoon for PAF
- Acronym: PERFECT-PAF
- Condition: Atril Fibrillation
- Condition: Cardiac Arrhythmia
- Condition: Paroxysmal Atrial Fibrillation (PAF)
- Intervention (Device): Single-Shot Pulsed Field Ablation (FARAPULSE™ Pulsed Field Ablation System)
- Intervention (Device): Single-Shot Cryoballoon Devices (Arctic Front Advance PRO, Medtronic Inc., Minneapolis, MN, USA; POLARx and POLARx FIT Balloon Catheter, Marlborough, MA, USA)
- Lead sponsor: Universitair Ziekenhuis Brussel
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: Universitair Ziekenhuis Brussel (`cardio:org-universitair-ziekenhuis-brussel`)

## Provenance

Content hash: eaa991c97ab28dc9854ee0d21c7a253fcda8c1e4742c582bdcebc629824cbffd
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
